Get the Stockscreener App
149.06
3.11%
4.49
After Hours:
149.06
Repligen Corp stock is traded at $149.06, with a volume of 1.18M.
It is up +3.11% in the last 24 hours and up +11.51% over the past month.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
See More
Previous Close:
$144.57
Open:
$145.76
24h Volume:
1.18M
Relative Volume:
1.29
Market Cap:
$8.39B
Revenue:
$633.51M
Net Income/Loss:
$-8.10M
P/E Ratio:
-480.84
EPS:
-0.31
Net Cash Flow:
$131.26M
1W Performance:
-10.38%
1M Performance:
+11.51%
6M Performance:
+8.02%
1Y Performance:
+11.02%
1-Day Range:
$144.21
$153.48
1-Week Range:
$144.18
$168.01
52-Week Range:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Name
Repligen Corp
Sector
Industry
Phone
(781) 449-9560
Address
41 SEYON STREET, WALTHAM, MA
Compare RGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
149.06 | 8.13B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
534.28 | 187.89B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
178.71 | 51.42B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.89 | 36.71B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
246.88 | 36.82B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
282.07 | 20.04B | 2.96B | 487.70M | 344.00M | 6.6758 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Initiated | HSBC Securities | Buy |
| Sep-22-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-22-25 | Resumed | Stephens | Overweight |
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-29-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Mar-18-25 | Initiated | Evercore ISI | In-line |
| Feb-10-25 | Initiated | TD Cowen | Buy |
| Dec-17-24 | Initiated | Canaccord Genuity | Hold |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-18-24 | Initiated | Guggenheim | Neutral |
| Dec-04-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Mar-28-23 | Initiated | The Benchmark Company | Buy |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-20-22 | Initiated | UBS | Buy |
| Oct-14-21 | Initiated | Exane BNP Paribas | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| May-07-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-23-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Nov-01-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-15-19 | Initiated | SVB Leerink | Outperform |
| Aug-28-19 | Reiterated | First Analysis Sec | Outperform |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jul-22-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Dec-17-18 | Upgrade | CL King | Neutral → Buy |
| Nov-12-18 | Downgrade | CL King | Buy → Neutral |
| Sep-26-18 | Initiated | H.C. Wainwright | Neutral |
| Dec-08-17 | Initiated | Citigroup | Buy |
| Dec-05-17 | Initiated | JP Morgan | Overweight |
| Nov-13-17 | Initiated | CL King | Buy |
| Oct-02-17 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Jul-21-17 | Initiated | William Blair | Outperform |
| Feb-13-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
View All
Repligen Corp Stock (RGEN) Latest News
Smart tools for monitoring Repligen Corporation’s price actionJuly 2025 Spike Watch & Community Consensus Trade Signals - newser.com
Pier Capital LLC Sells 4,692 Shares of Repligen Corporation $RGEN - MarketBeat
Geneva Capital Management LLC Purchases 343,991 Shares of Repligen Corporation $RGEN - MarketBeat
William Blair Has Negative View of Repligen FY2025 Earnings - MarketBeat
Custom strategy builders for tracking Repligen CorporationJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
William Blair Forecasts Reduced Earnings for Repligen - Defense World
FY2025 EPS Estimates for Repligen Cut by Leerink Partnrs - MarketBeat
Will Repligen Corporation (RGN) stock hit Wall Street targetsWeekly Trade Review & Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-10-31 03:24:45 - newser.com
Can volume confirm reversal in Repligen Corporation2025 Geopolitical Influence & Weekly Breakout Watchlists - newser.com
Repligen Corp (RGEN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market ... By GuruFocus - Investing.com Canada
Applying chart zones and confluence areas to Repligen CorporationWeekly Trade Analysis & Verified Momentum Stock Alerts - newser.com
Published on: 2025-10-29 21:31:23 - newser.com
Barclays Maintains Repligen (RGEN) Overweight Recommendation - Nasdaq
RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset - Yahoo Finance
Is Repligen Corporation stock attractive for ETFsJuly 2025 Recap & Verified Swing Trading Watchlist - newser.com
What makes Repligen Corporation stock attractive to growth funds2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - newser.com
Repligen: Q3 Earnings Snapshot - Stamford Advocate
Repligen shares rise 3% as Q3 revenue growth tops expectations - Investing.com
Earnings call transcript: Repligen Q3 2025 earnings beat expectations, stock rises - Investing.com Canada
Repligen Raises Outlook After Beating Revenue And Earnings Forecasts - Finimize
Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Repligen Corp Q3 2025 Earnings: EPS of $0.26 Beats Estimates, Re - GuruFocus
Repligen’s (NASDAQ:RGEN) Q3 Sales Beat Estimates - Yahoo Finance
Repligen earnings beat by $0.04, revenue topped estimates - Investing.com
Repligen Q3 2025 Earnings Beat Estimates, Raises Full-Year OutlookNews and Statistics - IndexBox
Repligen Corporation Reports Q3 2025 Financial Results - TradingView
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance - Yahoo Finance
Bessemer Group Inc. Sells 2,485 Shares of Repligen Corporation $RGEN - MarketBeat
Using data tools to time your Repligen Corporation exitJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Published on: 2025-10-28 02:23:27 - newser.com
What technical patterns form on Repligen Corporation (RGN) stock chartsJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
How Repligen Corporation stock compares to growth peersLong Setup & Short-Term Trading Opportunity Alerts - fcp.pa.gov.br
Earnings To Watch: Repligen Corp (RGEN) Reports Q3 2025 Result - Yahoo Finance
Is it time to cut losses on Repligen CorporationMarket Activity Recap & Weekly Sector Rotation Insights - newser.com
Will Repligen Corporation stock benefit from infrastructure spendingJuly 2025 Recap & Expert Curated Trade Ideas - newser.com
Repligen Earnings: What To Look For From RGEN - Barchart.com
Weiss Ratings Reaffirms Sell (D) Rating for Repligen (NASDAQ:RGEN) - MarketBeat
Does Repligen Corporation stock trade at a discount to peersMarket Sentiment Report & Real-Time Chart Pattern Alerts - newser.com
Technical signs of recovery in Repligen CorporationJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
Best Manufacturing Stocks To Watch TodayOctober 23rd - MarketBeat
Repligen Corp Stock (RGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.60%
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):